Cytology Codes & management Colposcopy- Management of cervical lesions

Slides:



Advertisements
Similar presentations
HPV Testing and Genotyping
Advertisements

Cervical Issues Annual update 2010 Tamsin Groom. Overview of screening and management Do’s and Don’ts The “suspicious cervix” Quiz.
MANAGEMENT OF ABNORMAL PAP SMEAR
Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Updates on Pap Smear Guidelines 2014
Sample Taker Training Cervical Cytology & Management of Abnormalities.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
Screening for Cervical Cancer
Benign and premalignant disease of the cervix
Cervical Cancer By: Kajal Haghmoradi.
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
wrong to say cervical erosion -this condition appear at ( puberty ) ( pregnancy )
Case Presentations: Pre-Invasive Cervical Neoplasia
COLPOSCOPY Cervical Screening QARC Training School October 2012.
04/05/20041 Liquid Based Cytology Workshop. 04/05/20042 Programme content Session 1 : Overview of the cervical screening programme & why LBC has been.
AN AUDIT OF PAP SMEAR, COLPOSCOPY AND HISTOLOGY RESULTS FROM IN TUNGARU CENTRAL HOSPITAL (KIRIBATI)
Cervical Cancer Screening
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Overview of NHS Cervical Screening Programme Cervical Screening QARC Training School October 2012.
Tumors of Cervix.
NHS Cervical Screening Programme, England, : Graphs.
Rajvinder Dhillon Specialist Biomedical Scientist & colposcopist
Cervical Intraepithelial Neoplasm
Adult Medical-Surgical Nursing
Cases. Case 2 Case 3 Normal cervix - Spatula and brush.
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
 Cervical cancer kills about women a year.  It’s the commonest cause of death from cancer in women.it’s the commonest after breast cancer. 
1 Cervical Screening Programme, England, : Graphs.
Premalignant lesions of the cervix. Applied anatomy.
CERVICAL SCREENING ANGELIKA KAUFMANN, ST4, UHCW, MEDICAL STUDENT INDUCTION, 2015.
COLPOSCOPY QUESTIONS Michael R. Downs M.D. October 2004.
NHS Cervical Screening Programme Introducing HPV triage and test of cure.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Chris Marshall Cardiff 4 th year Medical Student.
Cervical Screening: Do I Really Need a Pap Test April 2010.
1 Cervical Cancer Screening Updates Dr. GORDON JOHNSON.
Understanding Test Results
HPV and Cervical Cancer Screening
Cervical Screening- Implementation and local audit
Public Health England leads the NHS Screening Programmes
Trreatment of Preinvasive Lesions
NHS Cervical Screening Programme Introducing HPV Triage
INTRODUCTION: CERVICAL CANCER SCREENING
Cervical Cancer Colposcopy & Treatment
Cervical Screening Programme, England, : Graphs
The Accuracy of Diagnostic Colposcopy Using ISCCP 2011 Classification
NHS Cervical Screening Programme, England, : Graphs
Dr N Shailaja Dr Pradeep
Cervical cancer & screening
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
NHS Cervical Screening Programme, England : Graphs
Updates on Pap Smear Guidelines 2014
Public Health England leads the NHS Screening Programmes
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Cervical Screening for Dysplasia and Cancer in Patients with HIV
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA
Cervical Screening Programme
Presentation transcript:

Cytology Codes & management Colposcopy- Management of cervical lesions

Cytology codes 0/G-?Glandular neoplasia (non cervical) 1-Inadequate Specimen  2/N-Negative  3/M-Low grade dyskaryosis (CIN 1)  4-High grade dyskaryosis (severe) (CIN 3)  5-High grade dyskaryosis ?invasive squamous carcinoma  6-?Glandular neoplasia of endocervical type  7-High grade dyskaryosis (moderate) (CIN 2)  8/B-Borderline change in squamous cells  9/E-Borderline change in endocervical cells  X-No Cytology test undertaken 

Action Codes A-To be used for all cases where the next test is to be performed at the normal (routine) recall interval for the DHA responsible for the women.  R-To be used for all cases in which a further smear is recommended in an interval less than the routine recall interval of the DHA.  S-To be used for all cases where referral to a gynaecologist is recommended and for those smears from patients under the care of a gynaecologist or other relevant specialist.  H-Record the result and do not change current recall details.  

Cytology Infection Code Descriptions 0-Human Papilloma Virus (HPV) negative  1-Trichomonas  2-Candida  3-Wartvirus  4-Herpes  5-Actinomyces  6-Other (to be specified)  9-HPV positive  U-HPV unavailable  Q-No HPV test undertaken

Examples N0A 1R3 4S

Inadequate on 3 occasions Guidelines for referral to the Colposcopy Clinic Barts Health NHS Trust Inadequate on 3 occasions Borderline or mild dyskaryosis and high risk HPV positive Moderate or severe dyskaryosis ? Invasive or ? Glandular neoplasia 3 abnormal results over 10 years Clinically suspicious cervix or symptoms

The procedure of colposcopy When referring women for colposcopy all women should have explained to them: The procedure of colposcopy The possibility of a cervical biopsy

The Colposcope This is a binocular microscope that allows magnification and illumination of the cervix.

The Colposcopy Examination Acetic acid 5% is applied. The abnormality is identified (aceto-white change). The colposcopic examination is considered satisfactory when the entire transformation zone has been identified, and a colposcopic impression is made. A photograph may be taken for accurate follow up. One or more biopsies are then taken of the abnormal areas.

Acetic acid is applied to the surface of the cervix Acetic acid is applied to the surface of the cervix. The light from the colposcope is reflected back from the enlarged nuclei of the abnomal cells giving us the aceto-white change How Acetic acid works Acetic acid is applied to the surface of the cervix. The light from the colposcope is reflected back from the enlarged nuclei of the abnomal cells giving us the aceto-white change

Cervical punch biopsy forceps

Cervical Biopsies

Satisfactory Colposcopy

Unsatisfactory Colposcopy

Postmenopausal Cervix

Nabothian Cyst

Cervical Ectropion

Endocervical Polyp

HPV infection of the cervix Colposcopic Features Pale staining aceto-white lesion Irregular, indistinct margins of lesion Atypical vessels, fine mosaic pattern  

HPV Transmitted by intimate contact An estimated 80% of sexually active women will be exposed to the virus by age 50 Most infections will regress spontaneously after 6-12 months Over time persistent infection can lead to cancer and other HPV related diseases

CIN1 Mild aceto-white uptake Irregular, indistinct margins of lesion No obvious atypical vessels/mosaic pattern In most women, will revert back to normal given time. Approximately 5% of all smears show borderline or mild dyskaryosis.

Moderately dense aceto- white change with atypical CIN2 Moderately dense aceto- white change with atypical vessels, mosaic patterns and punctation. Approximately 1% of all smears show moderate dyskaryosis.

CIN3 Densely staining aceto-white lesion Straight margins Atypical vessels, coarse mosaicism, punctation Large volume lesion Poor iodine uptake Approximately 0.5% of all smears show severe dyskaryosis.

Micro-invasive lesions of the cervix Densely staining acetowhite lesion Atypical vessels, suspicious of invasion Often large volume lesions Poor iodine uptake May bleed easily Less than 0.1% of smears suggest invasive carcinoma.

Treatment – LLETZ (Large Loop Excision of the Transformation Zone) A diathermy pad is placed on the woman’s leg. Local anaesthesia is injected into the four quadrants of the cervix. An appropriately sized loop is chosen and the abnormal area removed in one piece under colposcopic guidance. Ball diathermy is used to achieve haemostasis. Facilities are available in the clinic in the event of an emergency situation. Follow up information is reinforced before the woman leaves the clinic.

LLETZ

What are the complications? Treatment for CIN is generally very safe. Very few complications exist but some important problems can occur. Bleeding. Infection. Cervical stenosis’ and ‘cervical incompetence’ Premature rupture of membranes during pregnancy leading to early delivery Women are advised not to insert ANYTHING into the vagina for at least 4 weeks.

What is the success rate? Ninety five percent of women have a negative smear 6 months following their first treatment.

Follow-up A follow-up check after treatment for precancerous changes is absolutely essential. We perform Liquid Based Cytology and HPV testing six months after treatment. If residual precancerous cells are left behind, further Colposcopy and biopsy is performed, and a repeat LLETZ procedure, will be arranged if necessary.

Changes to practice HPV testing TRIAGE Given that cervical cancer will not develop without HPV, women with borderline changes or mild dyskaryosis who have a negative high risk HPV test are not likely to need treatment and should be able to safely return to routine screening. TEST OF CURE It has now been clearly established that the successful removal of abnormal cervical cells usually also leads to the disappearance of the HPV within 12 months or so.

www.bsccp.org.uk www.jotrust.co.uk www.patient.co.uk Further Information www.bsccp.org.uk www.jotrust.co.uk www.patient.co.uk www.cancerscreening.nhs.uk www.londonqarc.nhs.uk